Alexium Receives Purchase Order From New Client

(firmenpresse) - PERTH, AUSTRALIA and GREER, SC -- (Marketwired) -- 05/08/15 -- (ASX: AJX) (OTCQX: AXXIY) is pleased to announce it has received a considerable purchase order from a new customer in the home furnishings market.
Over the past few months, Alexium has worked with a new customer to perform multiple short production-scale trials at the customer's facility using Alexium's Alexiflam™ chemistry, a process that has resulted in exceptional performance results.
Alexium has received a purchase order to run a substantial amount of yardage to confirm those results on a larger scale prior to a full commercial launch of the product. Upon the expected confirmation of those results, Alexium expects this to be a valuable relationship for both parties, generating between $3M and $10M annually in revenues to Alexium.
Nicholas Clark, CEO of Alexium, said, "We are continuing to generate strong interest in the commercial sector markets, and this opportunity with a major U.S. company in the home furnishings arena will help cement Alexium's reputation for environmentally-friendly, performance based, durable and cost effective Fire Retardant solutions."
On completion of contract negotiations and firm pricing, Alexium will provide a further update on this opportunity to the market.
For more information, visit Alexium's website at .
Alexium International Group Limited (ASX: AJX) (OTCQX: AXXIY) holds proprietary patent applications for a process developed initially by the U.S. Department of Defense, which allows for the surface modification and attachment of nano-particles or multiple chemical functional groups to surfaces or substrates to provide functions such as fire retardancy, water proofing, oil proofing, and anti-microbial treatments. Applications under development include but are not limited to textiles, paints, and packaging, glass and building materials. Alexium's fire retardant chemical treatment are currently marketed for different fabric markets under the Alexiflam™, Alexiflam-NF™ and Alexiflam-SYN™ trademarks. For more information on Alexium refer to the Company's website at .
Julie Patrick
Marketing & PR Specialist
U.S.: +1 864.908.6793
8 Distribution Court
Greer, SC 29650
T: +1 864.416.1060
F: +1 864.752.6465
148 Milestone Way
Greenville, SC 29615
T: +1 864.603.1165
F: +1 864.752.6465
Themen in dieser Pressemitteilung:
Unternehmensinformation / Kurzprofil:
Bereitgestellt von Benutzer: Marketwired
Datum: 08.05.2015 - 13:11 Uhr
Sprache: Deutsch
News-ID 391921
Anzahl Zeichen: 0
contact information:
Town:
PERTH, AUSTRALIA and GREER, SC
Kategorie:
Specialty Chemicals
Diese Pressemitteilung wurde bisher 239 mal aufgerufen.
Die Pressemitteilung mit dem Titel:
"Alexium Receives Purchase Order From New Client"
steht unter der journalistisch-redaktionellen Verantwortung von
Alexium International (Nachricht senden)
Beachten Sie bitte die weiteren Informationen zum Haftungsauschluß (gemäß TMG - TeleMedianGesetz) und dem Datenschutz (gemäß der DSGVO).